Medline Inc. Class A common stock (MDLN) is a publicly traded the market company. As of July 5, 2026, MDLN trades at $43.19 with a market cap of $36.52B and a P/E ratio of 0.00. MDLN moved +3.52% today. Year to date, MDLN is +3.03%; over the trailing twelve months it is flat. Its 52-week range spans $32.82 to $50.88. Analyst consensus is strong buy with an average price target of $51.89. Rallies surfaces MDLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MDLN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MDLN recently traded at $43.19. Market cap is $36.52B. P/E ratio is 0.00. Revenue is $29.14B.
| Metric | Value |
|---|---|
| Price | $43.19 |
| Market Cap | $36.52B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.88 |
| 52-Week Low | $32.82 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $29.14B |
| Net Income | $1.08B |
| Gross Margin | 25.86% |
20 analysts cover MDLN: 0 strong buy, 18 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.89.